You can read more about the power of momentum in assessing share price movements on Stockopedia. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. Have Watchlists? Explore strong past performing companies in the Food, Beverage & Tobacco industry. to determine if its dividend payments are covered by earnings. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. access. Is Arcadia Biosciences undervalued compared to its fair value and its price relative to the market? (2.5x) compared to the US Food industry average (2x). Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. than 75% of US stocks over the past 3 months. ( 2.8 years average tenure), which suggests a new board. He had been President of Arcadia Specialty Genomic. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada. 08:29 AM ET. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day. For more information, learn about our StockRank Styles. Price trends tend to persist, so it's worth looking at them when it comes to a share like Arcadia Biosciences Inc. Over the past six months, the relative strength of its shares against the market has been -35.84%. Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. Visit a quote page and your recently viewed tickers will be displayed here. Long Term Liabilities: RKDA's short term assets ($26.1M) exceed its long term liabilities ($15.8M). The stock has a 50-day moving average of … S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. Arguably, the recent bounce is to be expected after such a bad drop. Stable Dividend: Insufficient data to determine if RKDA's dividends per share have been stable in the past. Learn more here.
Earnings Trend: RKDA is unprofitable, and losses have increased over the past 5 years at a rate of 0.5% per year. How experienced are the management team and are they aligned to shareholders interests? : For the six months ended 30 June 2020, ArcadiaBiosciences Inc revenues increased 63% to $590K. This browser is no longer supported at MarketWatch. Arcadia Biosciences's stock swings to a loss of 10.5%, after being up as much as 5.9% earlier MarketWatch. He had been President of Arcadia Specialty Genomic ... Show more. Earnings vs Market: RKDA is forecast to remain unprofitable over the next 3 years. $2.9 Future Dividend Coverage: No need to calculate the sustainability of RKDA's dividend in 3 years as they are not forecast to pay a notable one for the US market. (11%) has been stable over the past year, but is still higher than 75% of US stocks. All quotes are in local exchange time. Copyright © 2020 MarketWatch, Inc. All rights reserved. She received an undergraduate degree from the University of Virginia and an MBA from Harvard Business School. Is Arcadia Biosciences (NASDAQ:RKDA) In A Good Position To Deliver On Growth Plans? Arcadia Biosciences Inc (NASDAQ:RKDA) Share Price and News. Return vs Industry: RKDA underperformed the US Food industry which returned 5.5% over the past year. Arcadia Biosciences, Inc., a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. Insufficient data to calculate RKDA's fair value to establish if it is undervalued. High Growth Revenue: RKDA's revenue (56.2% per year) is forecast to grow faster than 20% per year. View the real-time RKDA price chart on Robinhood and decide if you want to buy or sell commission-free. No need to calculate the sustainability of RKDA's dividend in 3 years as they are not forecast to pay a notable one for the US market. Shares in Arcadia Biosciences Inc are currently trading at $3.21 and the price has moved by -21.41% over the past 365 days. Experienced Management: RKDA's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team. In terms of relative price strength - which takes into account the overall market trend - the Arcadia Biosciences Inc price has moved by ( 1.2 years average tenure), which suggests a new team. Arcadia Biosciences, Inc., a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. Unable to evaluate RKDA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts. Notable Dividend: Unable to evaluate RKDA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts. /* sc-component-id: sc-iujRgT */ /* sc-component-id: sc-RefOD */ Debt Level: RKDA's debt to equity ratio (23.9%) is considered satisfactory. View recent trades and share price information for Arcadia Biosciences Inc USD0.001 Compensation vs Market: Matt's total compensation ($USD581.08K) is about average for companies of similar size in the US market ($USD563.91K). Hargreaves Lansdown is not responsible for an
PEG Ratio: Insufficient data to calculate RKDA's PEG Ratio to determine if it is good value. Shares in Arcadia Biosciences Inc are currently priced at $2.9. Arcadia Biosciences' stock up on heavy volume again, but pulls way back from earlier peak MarketWatch. RKDA's revenue (56.2% per year) is forecast to grow faster than the US market (9.8% per year). Log in to see them here or sign up to get started. Here are the trading details for Arcadia Biosciences Inc: Based on an overall assessment of its quality, value and momentum, Arcadia Biosciences Inc is currently classified as a Sucker Stock. Cookie Notice. Arcadia Biosciences Stock Price Forecast, RKDA stock price prediction. More Details, Revenue is forecast to grow 56.19% per year, Currently unprofitable and not forecast to become profitable over the next 3 years, Volatile share price over the past 3 months, Shareholders have been diluted in the past year. Below Fair Value: Insufficient data to calculate RKDA's fair value to establish if it is undervalued. Click here to write a private note about this stock.